Patent Assignment
Reel/Frame 056077/0698
Change of Name
Recorded: 2021-04-28
Pages: 4
Assignor
PLEDPHARMA AB
Executed: 2020-12-17
Assignee
EGETIS THERAPEUTICS AB
GREV TUREGATAN 11 C, 3 TR, STOCKHOLM, SE-114 46, SWEDEN
Covered Properties
(7)
Compounds for Use in the Treatment of Cancer
Pharmaceutical Compositions and Therapeutic Methods Employing a Combination of a Manganese Complex Compound and a Non-Manganese Complex Form of the Compound
Compounds for Use in the Treatment of Cancer
Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Methods and Formulations for Treatment of and/or Protection Against Acute Liver Failure and Other Hepatotoxic Conditions
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 5, 2010
From: KARLSSON, JAN OLOF G.; KURZ, TINO; ANDERSSON, ROLF
To: PLEDPHARMA AB
Reel/Frame 024798/0256 →
Assignment of Assignor's Interest
Dec 20, 2011
From: KARLSSON, JAN-OLOF; ANDERSSON, ROLF
To: PLEDPHARMA AB
Reel/Frame 027418/0531 →
Assignment of Assignor's Interest
Jun 19, 2015
From: KARLSSON, JAN-OLOF; REINEKE, KARL; KURZ, TINO; ANDERSSON, ROLF
To: PLEDPHARMA AB
Reel/Frame 035943/0138 →
Assignment of Assignor's Interest
Sep 25, 2018
From: NASSTROM, JACQUES; JACOBSSON, SVEN; HENRIKSEN, DENNIS; VAN ALSTINE, JAMES
To: PLEDPHARMA AB
Reel/Frame 046960/0040 →